Results 21 to 30 of about 1,955,704 (153)

A cost-effectiveness evaluation of methods for screening for TB infection in patients with diabetes mellitus [PDF]

IJTLD Open
BACKGROUND: Globally, 10.6 million TB cases occurred in 2021. Malaysia reported 25,000 TB cases in 2022, and also has a high prevalence of diabetes mellitus (DM), amplifying TB risks.
M.I. Mahmood, M. Ganason, Z.A. Aziz, S.H. Ramli, S.H.A. Halim   +4 more
doaj   +2 more sources

A detailed analysis of borderline results in the QuantiFERON-TB Gold-Plus assay incorporating longitudinal follow-up: intermediate-burden setting. [PDF]

Microbiol Spectr
The QuantiFERON-TB Gold Plus (QFT-Plus; Qiagen, Hilden, Germany) assay is widely used for latent TB infection (LTBI) screening; however, borderline results often show variability during follow-up.
Shin E, Ha C, Seo JD, Kim H, Hur M, Yun Y-M, Moon H-W.   +6 more
europepmc   +2 more sources

Immune Sensitization to Mycobacterium tuberculosis Among Young Children with and without Tuberculosis [PDF]

Pathogens
Identification of young children with Mycobacterium tuberculosis (Mtb) infection is critical to curb pediatric morbidity and mortality. The optimal test to identify young children with Mtb infection remains controversial.
Jesús Gutierrez, LaShaunda L. Malone, Mitchka Mohammadi, John Mukisa, Michael Atuhairwe, Simon Peter G. Mwesigwa, Salome Athieno, Sharon Buwule, Faith Ameda, Sophie Nalukwago, Ezekiel Mupere, Catherine M. Stein, Christina L. Lancioni   +12 more
doaj   +2 more sources

Comparison of Rifampin and Isoniazid for Latent Tuberculosis Infection in Kidney Transplant Candidates: Focus on Tolerability and Treatment Completion. [PDF]

Transpl Infect Dis
This study comparing 4‐month rifampin with 9‐month isoniazid for latent tuberculosis in kidney transplant candidates showed higher treatment completion rates and no transaminase elevations in the rifampin group. However, some patients experienced an increase in blood pressure while taking antihypertensive medications known to interact with rifampin ...
Simkins J, Viotti JB, Natori Y, Anjan S, Mattiazzi A, Ortigosa-Goggins M, Guerra G, Roth D, Kupin W, Pagan JA, Cabeza F, Ciancio G, Morsi M, Morris MI.   +13 more
europepmc   +2 more sources

QuantiFERON-TB Gold Plus for screening and monitoring latent tuberculosis infection in spondyloarthritis patients

Journal of Infection in Developing Countries
Introduction: The optimal frequency of rescreening for latent tuberculosis infection (LTBI) in patients with inflammatory arthritis on biologic/targeted-synthetic disease modifying anti-rheumatic drugs (b/ts-DMARDs) is uncertain.
Zehra Ozsoy, Adem Ozdemir, Mustafa Ekici, Emre Bilgin, Asena Eken, Zeynep Saribas, Ahmet C Inkaya, Deniz Koksal, Burcin Sener, Ihsan Ertenli, Omer Karadag, Levent Kilic   +11 more
doaj   +2 more sources

Standard E TB-Feron ELISA and Standard F TB-Feron FIA positivity rates and agreement with QuantiFERON-TB Gold Plus among TB high-risk population in Bandung, Indonesia

Journal of Clinical Microbiology
Tuberculosis (TB) remains a global public health problem. The determination of tuberculosis infection (TBI) using interferon-gamma release assay has now been used widely.
Dewi Kartika Turbawaty, Syifa Nur Maulida, Darin Rizka Anadhea, Mulyanusa Amarullah Ritonga, Basti Andriyoko, Rudi Wisaksana, Agnes Rengga Indrati, Nanny Natalia Mulyani Soetedjo, Laniyati Hamijoyo, Raspati Cundarani Koesoemadinata, Bachti Alisjahbana, Ida Parwati   +11 more
doaj   +2 more sources

Evaluation of QIAreach QuantiFERON-TB lateral-flow nanoparticle fluorescence assay for TB infection diagnosis among TB household contacts in three high-burden settings. [PDF]

PLoS ONE
BackgroundTuberculosis infection (TBI) testing, and treatment are fundamental to achieve TB elimination. TBI testing among close or household contacts (HHCs) has been limited, in part due to perceived complexity and high operational cost.
Thobani Ntshiqa, Akinlolu Fasanmi, Jeniffer Nagudi, Lindiwe Tsope, Andrew Copas, Stacie Stender, Issa Sabi, Elias Nyanda Ntinginya, Julieth Lalashowi, Manthomeng Matete, Lula Budiaki, Malebo Mahlalela, Abisai Kisinda, Don Mudzengi, Lilian Tina Minja, Tobias Chirwa, Knut Lönnroth, Stefan Niemann, Viola Dreyer, Salome Charalambous, Kavindhran Velen, Yohhei Hamada, Molebogeng Rangaka   +22 more
doaj   +2 more sources

Optimizing tuberculosis infection screening strategies for people living with HIV in Thailand: a cost-effectiveness analysis [PDF]

BMC Public Health
Background To support evidence-based decision-making in Thailand, we assessed the cost-effectiveness of QuantiFERON-TB Gold Plus (QFT-Plus) compared to the Tuberculin Skin Test (TST) in people living with HIV (PLWH).
Nuntana Chumpa, Pirapon June Ohata, Gompol Suwanpimolkul   +2 more
doaj   +2 more sources

Comparing patterns of recent and remote Mycobacterium tuberculosis infection determined using the QuantiFERON-TB Gold Plus assay in a high TB burden setting.

PLOS Global Public Health
One quarter of the world's population is estimated to be infected with Mycobacterium tuberculosis. Identifying recent TB infection (TBI) offers an avenue to targeted TB preventative therapy provision, and prevention to disease progression.
Modupe Amofa-Sekyi, Ab Schaap, Linda Mureithi, Barry Kosloff, Maina Cheeba, Bxyn Kangololo, Redwaan Vermaak, Robynn Paulsen, Maria Ruperez, Sian Floyd, Petra de Haas, Sarah Fidler, Richard Hayes, Helen Ayles, Kwame Shanaube, TREATS study team   +15 more
doaj   +2 more sources

Comparative evaluation of QuantiFERON-TB gold in-tube plus for Mycobacterium tuberculosis infection among adolescents in China

BMC Public Health
Summary To our knowledge, this is the first head-to-head study to evaluate QuantiFERON-TB Gold Plus, QuantiFERON-TB Gold In-Tube, ESAT6-CFP10, and tuberculin skin test among adolescents.
Peng Lu, Leonardo Martinez, Hao Xue, Qiao Liu, Xiaoyan Ding, Jingjing Pan, Hui Ding, Wei Lu, Limei Zhu, Jiangming Wang   +9 more
doaj   +2 more sources